LVAD placement in end-stage CHF patients 1) dramatically reduces mortality and improves Quality of Life (QOL) in patients too unstable to await cardiac transplantation, 2) achieves a degree of improvement in QOL comparable to transplantation, and 3) involves similar resource expenditures and quality and duration of time gained in survival.
Showing the most recent 10 out of 1103 publications